Fingerprint
Dive into the research topics of 'Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically